Funding for this research was provided by:
Novartis Pharma, Germany
Article History
Received: 17 September 2023
Revised: 22 March 2024
Accepted: 25 March 2024
First Online: 24 April 2024
Declarations
:
: U. Zeymer declares the receipt of payment or honoraria for lectures, presentations, speakers bureaus: AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Novartis, Pfizer, and Sanofi. R. Groves is an employee of Novartis Pharma GmbH, the funder of the study. S. Hupfer is an employee of Novartis Pharma GmbH, the funder of the study, and holds shares in Novartis.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.